Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Annals of Neurology|June 14, 2000
The role of B cells and autoantibodies in multiple sclerosisJ J Archelos, M K Storch, H P HartungJournal of Neural Transmission. Supplementum|August 29, 2000
Toxic effector molecules in the pathogenesis of immune-mediated disorders of the central nervous systemB C Kieseier, M K Storch, H P HartungCerebrovascular Diseases (Basel, Switzerland)|May 26, 2004
Midbrain ischemia presenting as vertical gaze palsy: value of diffusion-weighted magnetic resonance imagingT Seifert, C Enzinger, S Ropele, et al.Annals of Neurology|April 18, 1998
Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelinationM K Storch, S Piddlesden, M Haltia, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 18, 2005
Acute small subcortical infarctions on diffusion weighted MRI: clinical presentation and aetiologyT Seifert, C Enzinger, M K Storch, et al.Zeitschrift Fur Rheumatologie|August 8, 2008
[Diagnosis and therapy of neurological manifestations of inflammatory rheumatic diseases]C Dejaco, T Seifert, C Duftner, et al.Current Opinion in Neurology|September 28, 1999
Effector pathways in immune mediated central nervous system demyelinationB C Kieseier, M K Storch, J J Archelos, et al.European Journal of Neurology|September 1, 2005
Relapsing acute transverse myelitis: a specific entityT Seifert, C Enzinger, S Ropele, et al.Journal of Neuroscience Research|July 15, 1997
Demyelination induced by protein kinase C-activating tumor promoters in aggregating brain cell culturesS Pouly, M K Storch, J M Matthieu, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1994
Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitisS J Piddlesden, M K Storch, M Hibbs, et al.Pageof 2